TR200201182T2 - Kanser ve diğer hastalıkların tedavisine yönelik klorit çözeltileri - Google Patents

Kanser ve diğer hastalıkların tedavisine yönelik klorit çözeltileri

Info

Publication number
TR200201182T2
TR200201182T2 TR2002/01182T TR200201182T TR200201182T2 TR 200201182 T2 TR200201182 T2 TR 200201182T2 TR 2002/01182 T TR2002/01182 T TR 2002/01182T TR 200201182 T TR200201182 T TR 200201182T TR 200201182 T2 TR200201182 T2 TR 200201182T2
Authority
TR
Turkey
Prior art keywords
cancer
treatment
stabilized chlorite
chlorite matrix
diseases
Prior art date
Application number
TR2002/01182T
Other languages
English (en)
Turkish (tr)
Inventor
W. Kuhne Frederich
Kodelja V�Tam
Original Assignee
Oxo Chemie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxo Chemie Ag filed Critical Oxo Chemie Ag
Publication of TR200201182T2 publication Critical patent/TR200201182T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TR2002/01182T 1999-08-18 2000-08-18 Kanser ve diğer hastalıkların tedavisine yönelik klorit çözeltileri TR200201182T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14942999P 1999-08-18 1999-08-18

Publications (1)

Publication Number Publication Date
TR200201182T2 true TR200201182T2 (tr) 2002-08-21

Family

ID=22530238

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/01182T TR200201182T2 (tr) 1999-08-18 2000-08-18 Kanser ve diğer hastalıkların tedavisine yönelik klorit çözeltileri

Country Status (14)

Country Link
EP (1) EP1408994A2 (xx)
KR (1) KR20020038728A (xx)
CN (1) CN1378456A (xx)
AU (1) AU6913200A (xx)
CA (1) CA2382293A1 (xx)
IL (1) IL148189A0 (xx)
MX (1) MXPA02001724A (xx)
NO (1) NO20020751L (xx)
NZ (1) NZ517673A (xx)
PL (1) PL353769A1 (xx)
RU (1) RU2002106824A (xx)
TR (1) TR200201182T2 (xx)
WO (1) WO2001012205A2 (xx)
ZA (1) ZA200201726B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1687238B1 (de) 2003-11-21 2009-12-09 CytoTools AG Reaktive chlorverbindungen, deren derivate, anionen und salze sowie verfahren zu deren herstellung und verwendung
US20080292729A1 (en) * 2005-07-21 2008-11-27 Nuvo Research Inc. Stabilized Chlorite Solutions in Combination with Fluoropyrimidines for Cancer Treatment
AU2012297589C1 (en) 2011-12-22 2015-04-16 Nuvo Research Gmbh Liposomal compositions
CN112386606A (zh) * 2019-08-19 2021-02-23 卢序 一种有第二信使作用增加积极氧化压力的氧化剂的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3515748A1 (de) * 1985-05-02 1986-11-06 Oxo Chemie GmbH, 6900 Heidelberg Verwendung einer isotonen chloritmatrix-loesung bei der behandlung von tumoren
DE3515749A1 (de) * 1985-05-02 1986-11-06 Oxo Chemie GmbH, 6900 Heidelberg Verwendung einer stabilisierten chloritmatrixloesung bei infektioesen zustaenden
ES2217582T3 (es) * 1997-10-06 2004-11-01 Oxo Chemie Ag Uso de una disolucion de clorito quimicamente estabilizada para inhibir una respuesta inmunitaria especifica de un antigeno.
AU2912300A (en) * 1999-02-19 2000-09-04 Kurt-Wilhelm Prof. Dr. Dr. Stahl Peroxochloric acid, derivatives and anions, salts thereof, method for producing them and use of the same

Also Published As

Publication number Publication date
KR20020038728A (ko) 2002-05-23
EP1408994A2 (en) 2004-04-21
RU2002106824A (ru) 2003-11-27
WO2001012205A2 (en) 2001-02-22
NZ517673A (en) 2004-03-26
CN1378456A (zh) 2002-11-06
MXPA02001724A (es) 2004-09-06
AU6913200A (en) 2001-03-13
WO2001012205A3 (en) 2001-09-13
NO20020751L (no) 2002-04-17
ZA200201726B (en) 2003-12-31
NO20020751D0 (no) 2002-02-15
CA2382293A1 (en) 2001-02-22
IL148189A0 (en) 2002-09-12
PL353769A1 (en) 2003-12-01

Similar Documents

Publication Publication Date Title
RS50939B (sr) 2-fenil benzimidazoli i imidazo-/4,5/-piridini kao cdsi/chk2 -inhibitori i pomoćna sredstva u hemoterapiji ili terapiji zračenja pri lečenju kancera
TR199800815A2 (en) S�lfonilaminokarbonasitler.
TR200100805T2 (tr) Tetrahidropiridoeterler
ATE451644T1 (de) Speichersteuerung, die prozessorenergiezustände berücksichtigt
ES2000734A6 (es) Un procedimiento para la preparacion de pirimidinas
DE69926407D1 (de) Behandlung von krebs mit tetraethylthiuramdisulfid
DE68921979D1 (de) Antikörper für die antilymphozyten-antikörpertherapie.
DE69620639D1 (de) Mercaptoalkylpeptidylverbindungen mit einem imidazolsubstituenten und ihre verwendung als inhibitoren der matrix metalloproteinasen (mmp) und/oder des tumor necrosis faktors (tnf)
NO982570D0 (no) Benzofurankarboksamider og -sulfonamider
TR200201182T2 (tr) Kanser ve diğer hastalıkların tedavisine yönelik klorit çözeltileri
DK1051395T3 (da) N-hydroxyformamidderivater
NO20040101L (no) Hemming av apoptoseprosessen og forbedring av cellenes yteevne
NO890046D0 (no) Disubstituerte pyridiner.
WO2003026580A3 (en) Interactive therapeutic enclosures
AU2002357644A1 (en) Therapeutic agents and corresponding treatments
DE60323529D1 (de) Rutheniumkomplexe mit antikrebswirkung
TR199903074T2 (xx) Kanser tedavisinde HMG CoA ve farnesil transfer �nleyicileri.
ATE285247T1 (de) Krebstherapie mit lymphotoxin
WO2003074547A3 (en) Biologically active complex comprising alpha-lcatalbumin or a variant thereof, and a cofactor
ATE194499T1 (de) Krebs therapie
DE60042273D1 (de) Antitumorantikörper, proteine und deren verwendung
DE68902396D1 (de) 1h-indazol-3-essigsaeure als aldose-reduktase-inhibitoren.
JPS549511A (en) Digital gain control system using read only memory
WO2003086298A3 (en) Use of interleukin-19 to treat ovarian cancer
DK1250422T3 (da) Myeloid-kolonistimulerende faktor og anvendelser deraf